Pharma

The AIPPI Pharma Committee monitors, comments and advises AIPPI on policy, regulatory and legal frameworks relating to intellectual property protection for pharmaceutical products and processes, diagnostic products and medical devices. The Committee also considers policy initiatives, and best practices for national and regional legislation.

Position paper on the waiver for certain provisions of the TRIPS agreement for the prevention, containment and treatment of COVID-19 proposed by some countries within the WTO.

Terms of Reference.

Standing Committee

Pharma

Status: Active

Committee Leadership

John C. TODARO (US ) (Chair)
Charles Aaron BOULAKIA (CA) (Vice Chair)
Martin KLOK (NL) (Vice Chair)
() ()

Committee Members

Heidi ADLER (FI)
Hameeda ASIF (PK)
Ezgi BAKLACI GÜLKOKAR (TR)
Martín BENSADON (AR)
Cristina BIGGI (IT)
Anna BLADH REDZIC (SE)
Brigitte CARION TARAVELLA (FR)
Héctor E. CHAGOYA C. (MX)
I. Soley COBAN (TR)
Magali CONTARDI (IT)
Daphné DEROUANE (BE)
Kevin CW FENG (TW)
Carlos FERNANDEZ DAVILA (PE)
Pablo FUENTES (MX)
David GILAT (IL)
Rana GOSAIN (BR)
Simon HOLZER (CH)
Shinji ISHIZU (JP)
Sevda Selime KALYONCU (TR)
Renat KRASNOPEROV (RU)
Malathi LAKSHMIKUMARAN (IN)
Jennifer LEE (US)
Hyon-Kyong (Monica) LEEU (KR)
Johanna LILJA (FI)
Anja LUNZE (DE)
Juhua LUO (CN)
Daisy MACHYTKA-FRANK (HU)
Wojciech MARCINIAK (PL)
Ilan MILLER (IL)
Muriel MOREL-PECHEUX (FR)
Rohaldy MULUK (ID)
Anita NADOR (CA)
Masaru NAKAJIMA (JP)
Carlos R. OLARTE (CO)
Juan Carlos QUERO (ES)
S M Zillur RAHMAN (BD)
Beat RAUBER (CH)
Mathilde RAULINE (FR)
Markus RIECK (DE)
Andrés RINCON USCATEGUI (CO)
Laura ROMESTANT (FR)
Christophe RONSE (BE)
Ashley ROUGHTON (UK)
Nicolas Vincent RUIZ (ES)
Ana Paula SANTOS CELIDÔNIO (BR)
Eliza SAUNDERS (AU)
Joseph SCHMITZ (CH)
Yoshinori SHIMIZU (JP)
Yoon S. SHIN (KR)
Kassandra SHORTT (CA)
Daniel SIEVEKING (AU)
Joseph SNYDER (US)
Archana Shanker SRIVASTAVA (IN)
David TIROSH (IL)
Shohta UENO (UK)
XINLEI WANG (CN)
Responsible Reporters
Ralph NACK (DE)